Search research articles
Contact Us
Filters
Showing results (91-100 of 1,398) with videos related to
Page
of 140
Sort By:
Expert Opinion on Pharmacotherapy
|
October 25, 2006
Point mutations of protein kinases and individualised cancer therapy
Michael Davies, Bryan Hennessy, Gordon B Mills
Oncoscience
|
January 17, 2015
Shrewd AKT regulation to survive
Moez Dawood, Gordon B Mills, Zhiyong Ding
Perfusion
|
July 4, 2012
Intimal hyperplasia: slow but deadly
B Mills, T Robb, D F Larson
Transactions of the Ophthalmological Societies of the United Kingdom
|
January 1, 1981
Two blind randomized cross-over trials in the treatment of primary open angle glaucoma
K B Mills, B Hercules, M English
Reviews in Clinical and Experimental Hematology
|
February 7, 2004
Targeting PI3K-AKT pathway for cancer therapy
Yiling Lu, Hongwei Wang, Gordon B Mills
Nature Reviews. Cancer
|
October 25, 2008
Derailed endocytosis: an emerging feature of cancer
Yaron Mosesson, Gordon B Mills, Yosef Yarden
Proceedings of the National Academy of Sciences of the United States of America
|
August 30, 2001
Linking molecular therapeutics to molecular diagnostics: inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo
G B Mills, Y Lu, E C Kohn
Neoplasia (New York, N.Y.)
|
January 8, 2019
Genome-Wide Analysis of Head and Neck Squamous Cell Carcinomas Reveals HPV, TP53, Smoking and Alcohol-Related Allele-Based Acquired Uniparental Disomy Genomic Alterations
Musaffe Tuna, Christopher I Amos, Gordon B Mills
Cancer Discovery
|
September 4, 2014
RADical response puts an exceptional responder in CHKmate: a synthetic lethal curative response to DNA-damaging chemotherapy?
Guang Peng, Scott E Woodman, Gordon B Mills
Dimensions in Health Service
|
August 1, 1979
Meeting the challenge of critical care nursing
S Murray, P Raftery, B Mills, et al.
Page
of 140
Search research articles
Search
Showing results (91-100 of 1,398) with videos related to
Sort By:
Page
of 140
Expert Opinion on Pharmacotherapy
|
October 25, 2006
Point mutations of protein kinases and individualised cancer therapy
Michael Davies, Bryan Hennessy, Gordon B Mills
Oncoscience
|
January 17, 2015
Shrewd AKT regulation to survive
Moez Dawood, Gordon B Mills, Zhiyong Ding
Perfusion
|
July 4, 2012
Intimal hyperplasia: slow but deadly
B Mills, T Robb, D F Larson
Transactions of the Ophthalmological Societies of the United Kingdom
|
January 1, 1981
Two blind randomized cross-over trials in the treatment of primary open angle glaucoma
K B Mills, B Hercules, M English
Reviews in Clinical and Experimental Hematology
|
February 7, 2004
Targeting PI3K-AKT pathway for cancer therapy
Yiling Lu, Hongwei Wang, Gordon B Mills
Nature Reviews. Cancer
|
October 25, 2008
Derailed endocytosis: an emerging feature of cancer
Yaron Mosesson, Gordon B Mills, Yosef Yarden
Proceedings of the National Academy of Sciences of the United States of America
|
August 30, 2001
Linking molecular therapeutics to molecular diagnostics: inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo
G B Mills, Y Lu, E C Kohn
Neoplasia (New York, N.Y.)
|
January 8, 2019
Genome-Wide Analysis of Head and Neck Squamous Cell Carcinomas Reveals HPV, TP53, Smoking and Alcohol-Related Allele-Based Acquired Uniparental Disomy Genomic Alterations
Musaffe Tuna, Christopher I Amos, Gordon B Mills
Cancer Discovery
|
September 4, 2014
RADical response puts an exceptional responder in CHKmate: a synthetic lethal curative response to DNA-damaging chemotherapy?
Guang Peng, Scott E Woodman, Gordon B Mills
Dimensions in Health Service
|
August 1, 1979
Meeting the challenge of critical care nursing
S Murray, P Raftery, B Mills, et al.
Page
of 140